Brighton Collaboration
The Brighton Collaboration (BC) is a non-profit global vaccine safety research network for health care professionals, named after the city in England where the idea was first formulated.
 Service Mark of the Brighton Collaboration Foundation | |
| Formation | 2000 |
|---|---|
| Type | NPO |
| Purpose | Safest, effective vaccines based on rigorous science To enhance the science of vaccine research by providing standardized, validated, and objective methods for continuous monitoring of safety profiles and by assessing benefit-risk ratios. These methods are, in turn, recognized and recommended for use by international regulatory and public health agencies.[1] |
| Headquarters | Basel, Switzerland |
Region served | Worldwide |
Official language | English |
| Leader | Jan Bonhoeffer, president |
| Website | brightoncollaboration.us |
The Brighton Collaboration was launched in 2000, although the idea of the collaboration started one year earlier, following a presentation by Bob Chen at an international scientific vaccine conference in Brighton. In his talk, he stressed the need to improve vaccine safety monitoring by developing internationally accepted standards.[2]
References
- "EVI and Brighton Collaboration Foundation (BCF) sign Memorandum of Understanding (MoU)". Archived from the original on 2011-10-31. Retrieved 2012-07-17.
- Chen RT (1999). "Vaccine risks: real, perceived and unknown". Vaccine. 17 Suppl 3: S41-6. doi:10.1016/s0264-410x(99)00292-3. PMID 10559533.
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.